Progress in breast cancer adjuvant endocrine therapy 6 (12): 1948 - 1955. Demicheli R, Terenziani M, Valagussa P, et al. Local recurrences following mastectomy: support for the concept of tumor dormancy [J]. J Natl Cancer Inst, 1994, 86 (1): 45 ~ 48. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer [J]. N Engl J Med, 2002, 347 (16): 1233-1241. Yin W, Di G, Zhou L, et al. Time-varying pattern of recurrence risk for Chinese breast cancer patients [J]. Breast Cancer Res Treat, 2008 ~ [Epub ahead of print]. Fisher B, Moncler Mont, Coyle J, Rudock C, Moncler Jackets, et al. Presence of a growth-stimulating factor in serum following primary tumor removal in mice [J]. Cancer Res, 1989, 49 (8): 1996-2001. Gunduz NFB, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor [J]. Cancer Res, 1979, 39 (10): 3861-3865. Hofer SO, UGGS Outlet, Shrayer D, Reichner JS, et al. Wound-induced tumor progression: a probable role in recurrence after tumor resection [J], Arch Surg, 1998, 133 (4): 383-389. Cui X, Zhang P, Moncler Sales, Deng W, MBT Shoes Milan, et al. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3 kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer [J]. Mol E 26 (May 20 Suppl): abstr LBA4.